Ethyl 5-(2,4,6-Trimethylphenyl)-5-oxovalerate, 97.0%, 1g

5-Ethyl-4-methyl-2-phenyl-2H-pyrazol-3-ylamine, 95.0%, 1g

Methyl mycophenolate, 10mg

5-(2-Hydroxyethyl)-3,4-dimethylthiazol-3-ium iodide, 97.0%, 1g

Fmoc-D-Ala-OH.H2O, 97.0%, 10g

2-Bromo-4-(4-methyl-piperazin-1-yl)-phenylamine, 95.0%, 1g

GC capillary column ROTI®Cap-1, 30 m, 0.25 mm, 0.10 µm, 1 Piece(s)

5-Bromo-6'-methyl-[2,3']bipyridinyl, 97.0%, 2g

2-(5-BROMO-1,3-THIAZOL-2-YL)PROPAN-2-OL, 95%, 1g

1-[6-(Trifluoromethyl)pyridin-2-yl]piperidine-4-carboxylic acid, 97.0%, 100mg

3,4-Dimethyl-5-nitrophenol, 95+%, 1g

(2E)-3-[4-(benzyloxy)phenyl]-1-(3-nitrophenyl)prop-2-en-1-one, 95.0%, 10g

2-(3-Bromophenyl)-1H-indole, 95.0%, 25g